PT3833378T - Tratamento de verrugas - Google Patents

Tratamento de verrugas

Info

Publication number: PT3833378T
Authority: PT; Portugal
Prior art keywords: warts; treatment
Prior art date: 2018-08-06

Application number

PT198464612T

Other languages

English (en)

Original Assignee

Nielsen Biosciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-08-06

Filing date

2019-08-05

Publication date

2025-06-06

2019-08-05 Application filed by Nielsen Biosciences Inc filed Critical Nielsen Biosciences Inc

2025-06-06 Publication of PT3833378T publication Critical patent/PT3833378T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Natural Medicines & Medicinal Plants (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Botany (AREA)
Alternative & Traditional Medicine (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PT198464612T 2018-08-06 2019-08-05 Tratamento de verrugas PT3833378T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201862714942P	2018-08-06	2018-08-06
US201962880742P	2019-07-31	2019-07-31

Publications (1)

Publication Number	Publication Date
PT3833378T true PT3833378T (pt)	2025-06-06

Family

ID=69228147

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT198464612T PT3833378T (pt)	2018-08-06	2019-08-05	Tratamento de verrugas

Country Status (13)

Country	Link
US (5)	US11116808B2 (pt)
EP (2)	EP3833378B1 (pt)
JP (2)	JP7546566B2 (pt)
KR (1)	KR20210044805A (pt)
CN (1)	CN112955167A (pt)
BR (1)	BR112021002156A2 (pt)
CA (1)	CA3108739A1 (pt)
DK (1)	DK3833378T3 (pt)
ES (1)	ES3031213T3 (pt)
FI (1)	FI3833378T3 (pt)
MX (3)	MX2021001502A (pt)
PT (1)	PT3833378T (pt)
WO (1)	WO2020033329A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL293214A (en)	2019-11-22	2022-07-01	Veradermics Incorporated	Microneedle patch for immunostimulatory drug delivery
IL307205A (en) *	2021-03-23	2023-11-01	Veradermics Incorporated	Perilesional treatment of skin conditions
WO2025240443A1 (en)	2024-05-14	2025-11-20	University Of Rochester	Candida for use in prevention or mitigation of cutaneous viral infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5614538A (en) *	1994-12-05	1997-03-25	Olin Corporation	Synergistic antimicrobial composition containing pyrithione and alcohol
US6270781B1 (en) *	1999-01-08	2001-08-07	Maxim Pharmaceuticals, Inc.	Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
CA2276219A1 (en) *	1999-06-25	2000-12-25	Board Of Trustees Of The University Of Arkansas	Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US6350451B1 (en)	1999-06-25	2002-02-26	The Board Of Trustees Of The University Of Arkansas	Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
US20050175634A1 (en) *	1999-06-25	2005-08-11	The Board Of Trustees Of The University Of Arkansas	Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
BR0111956A (pt)	2000-06-26	2003-05-13	Stressgen Biotechnologies Corp	Tratamento do vìrus do papiloma humano
GB0406013D0 (en) *	2004-03-17	2004-04-21	Chiron Srl	Analysis of saccharide vaccines without interference
CN101914458B (zh) *	2010-02-09	2013-03-13	北京万特尔生物制药有限公司	白假丝酵母(甘露糖蛋白质复合体)菌毛株
EP2574170A4 (en) *	2010-05-10	2013-11-20	Ascend Biopharmaceuticals Pty Ltd	IMMUNOSTIMULATORY AND VACCINE COMPOSITIONS
EP2869821A4 (en) *	2012-07-03	2016-04-06	Justice E Obi	COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS
CN105188747A (zh) *	2013-02-01	2015-12-23	葛兰素史密斯克莱生物公司	包含toll样受体激动剂的免疫组合物的皮内递送
JP2016538333A (ja) *	2013-10-13	2016-12-08	ザボードオブトラスティーズオブザユニバーシティオブアーカンソー	ヒトパピローマウイルス治療ワクチン

2019
- 2019-08-05 MX MX2021001502A patent/MX2021001502A/es unknown
- 2019-08-05 BR BR112021002156-6A patent/BR112021002156A2/pt unknown
- 2019-08-05 KR KR1020217006449A patent/KR20210044805A/ko active Pending
- 2019-08-05 JP JP2021531452A patent/JP7546566B2/ja active Active
- 2019-08-05 ES ES19846461T patent/ES3031213T3/es active Active
- 2019-08-05 WO PCT/US2019/045153 patent/WO2020033329A1/en not_active Ceased
- 2019-08-05 EP EP19846461.2A patent/EP3833378B1/en active Active
- 2019-08-05 DK DK19846461.2T patent/DK3833378T3/da active
- 2019-08-05 EP EP25164848.1A patent/EP4588487A3/en active Pending
- 2019-08-05 FI FIEP19846461.2T patent/FI3833378T3/fi active
- 2019-08-05 CN CN201980059582.1A patent/CN112955167A/zh active Pending
- 2019-08-05 CA CA3108739A patent/CA3108739A1/en active Pending
- 2019-08-05 PT PT198464612T patent/PT3833378T/pt unknown
- 2019-08-05 US US16/532,247 patent/US11116808B2/en active Active
2021
- 2021-02-05 MX MX2025004901A patent/MX2025004901A/es unknown
- 2021-02-05 MX MX2025004900A patent/MX2025004900A/es unknown
- 2021-07-16 US US17/378,411 patent/US11666617B2/en active Active
2023
- 2023-04-21 US US18/304,629 patent/US11963991B2/en active Active
2024
- 2024-03-19 US US18/609,229 patent/US12440526B2/en active Active
- 2024-08-23 JP JP2024143365A patent/JP2024164177A/ja active Pending
2025
- 2025-08-12 US US19/297,404 patent/US20250367248A1/en active Pending

Also Published As

Publication number	Publication date
JP2024164177A (ja)	2024-11-26
US11963991B2 (en)	2024-04-23
MX2021001502A (es)	2021-07-15
WO2020033329A1 (en)	2020-02-13
US20240226213A1 (en)	2024-07-11
US20200038464A1 (en)	2020-02-06
ES3031213T3 (en)	2025-07-07
EP3833378B1 (en)	2025-03-26
JP2021535197A (ja)	2021-12-16
US20210401913A1 (en)	2021-12-30
EP4588487A3 (en)	2025-10-15
EP3833378A1 (en)	2021-06-16
CA3108739A1 (en)	2020-02-13
DK3833378T3 (da)	2025-06-10
EP4588487A2 (en)	2025-07-23
BR112021002156A2 (pt)	2021-05-11
US20200376054A9 (en)	2020-12-03
MX2025004900A (es)	2025-06-02
FI3833378T3 (fi)	2025-06-16
US20250367248A1 (en)	2025-12-04
MX2025004901A (es)	2025-06-02
KR20210044805A (ko)	2021-04-23
US11116808B2 (en)	2021-09-14
US11666617B2 (en)	2023-06-06
EP3833378A4 (en)	2022-07-13
CN112955167A (zh)	2021-06-11
US12440526B2 (en)	2025-10-14
JP7546566B2 (ja)	2024-09-06
US20230256042A1 (en)	2023-08-17

Publication	Publication Date	Title
ZA202006746B (en)	2023-03-29	Methods of treatment
GB201804514D0 (en)	2018-05-02	Treatment of pyroptosis
IL278618B2 (en)	2025-11-01	Cancer treatment
GB201805100D0 (en)	2018-05-09	Treatment of sarcopenic diseases
ZA201705847B (en)	2020-03-25	Treatment of pain
GB201804515D0 (en)	2018-05-02	Treatment of necroptosis
PT3833378T (pt)	2025-06-06	Tratamento de verrugas
GB201907305D0 (en)	2019-07-10	Treatment of conditions
SG11202005850VA (en)	2020-07-29	Methods of treatment of hypertrigl yceridemia
ZA201900984B (en)	2019-12-18	Methods and compositions for the treatment of warts
PL3713572T3 (pl)	2025-09-22	Leczenie tachykardii
EP3503965B8 (en)	2022-03-09	Treatment of cardiac dysfunction
GB201918853D0 (en)	2020-02-05	Methods of treatment
SG11202105877YA (en)	2021-07-29	Method of treatment
IL290983A (en)	2022-05-01	Treatment methods
EP3532045A4 (en)	2020-07-22	USE OF SENICAPOC FOR THE TREATMENT OF NEUROPATHIC PAIN
EP3271017A4 (en)	2018-11-14	Treatment of skin conditions
GB201820975D0 (en)	2019-02-06	Methods of cancer treatment
GB201820098D0 (en)	2019-01-23	Methods of cancer treatment
IL257225A (en)	2018-04-09	Treatment of sarcoma
IL272124A (en)	2020-03-31	Treatment of non-inflammatory lesions
GB201900942D0 (en)	2019-03-13	Methods of treatment
HK40032171A (en)	2021-03-19	Combination treatment of sarcoglycanopathies
GB201917253D0 (en)	2020-01-08	Treatment of conditions
GB201801249D0 (en)	2018-03-14	Methods of treatment